REQUEST A DEMO
Total
USD $0.00
Search more companies

Unipharm del Ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Unipharm del Ecuador S.A. Profile Updated: February 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Unipharm del Ecuador S.A. is based in Ecuador, with the head office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on April 01, 2004. It currently has a total number of 27 (2024) employees. From the latest financial highlights, Unipharm del Ecuador S.A. reported a net sales revenue drop of 14.89% in 2024. Its’ total assets recorded a growth of 46.68%. The net profit margin of Unipharm del Ecuador S.A. decreased by 0.42% in 2024.

Headquarters
Av. Manuel Cordova Galarza Km 7 1/2, Leterago Bldg.
Quito; Pichincha;

Contact Details: Purchase the Unipharm del Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Unipharm del Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Unipharm del Ecuador S.A. report to view the information.
Financial Auditors:
Purchase the Unipharm del Ecuador S.A. report to view the information.
Incorporation Date:
April 01, 2004
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Unipharm del Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-14.89%
Total operating revenue
-15.31%
Operating Profit/Loss (EBIT)
7.75%
EBITDA
7.86%
Net Profit/Loss for the Period
11.52%
Total Assets
46.68%
Total Equity
-179.77%
Operating Profit Margin (ROS)
-1.07%
Net Profit Margin
-0.42%
Return on Equity (ROE)
-138.92%
Debt/Equity
9.21%
Quick Ratio
-0.09%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?